Table of Contents Author Guidelines Submit a Manuscript
Bioinorganic Chemistry and Applications
Volume 2009 (2009), Article ID 914105, 6 pages
http://dx.doi.org/10.1155/2009/914105
Research Article

Synthesis, Characterization, Antibacterial and Anti-Inflammatory Activities of Enoxacin Metal Complexes

1Department of Chemistry, University of Karachi, Karachi-75270, Pakistan
2Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Karachi, Karachi-75270, Pakistan
3PCMD, International Centre of Chemical Sciences, University of Karachi, Karachi-75270, Pakistan

Received 27 January 2009; Revised 25 March 2009; Accepted 4 May 2009

Academic Editor: Patrick Bednarski

Copyright © 2009 Saeed Arayne et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. J. Wood, “Tissue penetration and clinical efficacy of enoxacin in respiratory tract infections,” Clinical Pharmacokinetics, vol. 16, pp. 38–45, 1989. View at Google Scholar
  2. J. H. Paton and D. S. Reeves, “Fluoroquinolone antibiotics. Microbiology, pharmacokinetics and clinical use,” Drugs, vol. 36, no. 2, pp. 193–228, 1988. View at Google Scholar
  3. N. X. Chin and H. C. Neu, “In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin, new β-lactams, aminoglycosides, and trimethoprim,” Antimicrobial Agents and Chemotherapy, vol. 24, no. 5, pp. 754–763, 1983. View at Google Scholar
  4. J. Matsumoto, T. Miyamoto, A. Minamida, Y. Nichimura, H. Egawa, and H. Nishimura, “1,4-Dihydro-4-oxopyridinecarboxylic acids as antibacterial agents. 2. Synthesis and structure-activity relationships of 1,6,7-trisubstituted 1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids, including enoxacin, a new antibacterial agent,” Journal of Medicinal Chemistry, vol. 27, pp. 293–301, 1984. View at Google Scholar
  5. L. A. Jaber, E. M. Bailey, and M. J. Rybak, “Enoxacin: a new fluoroquinolone,” Clinical Pharmacy, vol. 8, no. 2, pp. 97–107, 1989. View at Google Scholar
  6. E. K. Efthimiadou, G. Psomas, Y. Sanakis, N. Katsaros, and A. Karaliota, “Metal complexes with the quinolone antibacterial agent N-propyl-norfloxacin: synthesis, structure and bioactivity,” Journal of Inorganic Biochemistry, vol. 101, no. 3, pp. 525–535, 2007. View at Publisher · View at Google Scholar
  7. T. Motoya, M. Miyashita, A. Kawachi, and K. Yamada, “Effects of ascorbic acid on interactions between ciprofloxacin and ferrous sulphate, sodium ferrous citrate or ferric pyrophosphate, in mice,” Journal of Pharmacy and Pharmacology, vol. 52, no. 4, pp. 397–401, 2000. View at Google Scholar
  8. M. Nakano, M. Yamamoto, and T. Arita, “Interactions of aluminum, magnesium, and calcium ions with nalidixic acid,” Chemical and Pharmaceutical Bulletin, vol. 26, no. 5, pp. 1505–1510, 1978. View at Google Scholar
  9. M. Ruiz, R. Ortiz, L. Perello, S. Granda, and M. R. Diaz, “Synthesis and characterization of Cd(II) complexes of cinoxacin. Crystal structure of a dicadmium complex containing two monoatomic-bridging carboxylate oxygen atoms,” Inorganica Chimica Acta, vol. 217, no. 1-2, pp. 149–154, 1994. View at Google Scholar
  10. M. Ruiz, L. Perello, J. Cario et al., “Cinoxacin complexes with divalent metal ions. Spectroscopic characterization. Crystal structure of a new dinuclear Cd(II) complex having two chelate-bridging carboxylate groups. Antibacterial studies,” Journal of Inorganic Biochemistry, vol. 69, no. 4, pp. 231–239, 1998. View at Publisher · View at Google Scholar
  11. I. Turel, I. Leban, G. Klintschar, N. Bukovec, and S. Zalar, “Synthesis, crystal structure, and characterization of two metal-quinolone compounds,” Journal of Inorganic Biochemistry, vol. 66, no. 2, pp. 77–82, 1997. View at Publisher · View at Google Scholar
  12. I. Turel, I. Leban, and N. Bukovec, “Crystal structure and characterization of the bismuth(III) compound with quinolone family member (ciprofloxacin). Antibacterial study,” Journal of Inorganic Biochemistry, vol. 66, no. 4, pp. 241–245, 1997. View at Publisher · View at Google Scholar
  13. B. Macias, M. V. Villa, I. Rubio, A. Castineiras, and J. Borras, “Complexes of Ni(II) and Cu(II) with ofloxacin: crystal structure of a new Cu(II) ofloxacin complex,” Journal of Inorganic Biochemistry, vol. 84, no. 3-4, pp. 163–170, 2001. View at Google Scholar
  14. Z.-F. Chcn, R.-G. Xiong, J.-L. Zuo, Z. Guo, X.-Z. You, and H.-K. Funb, “X-Ray crystal structures of Mg2+ and Ca2+ dimers of the antibacterial drug norfloxacin,” Journal of the Chemical Society, Dalton Transactions, no. 22, pp. 4013–4014, 2000. View at Publisher · View at Google Scholar
  15. N. Jiménez-Garrido, L. Perelló, R. Ortiz et al., “Antibacterial studies, DNA oxidative cleavage, and crystal structures of Cu(II) and Co(II) complexes with two quinolone family members, ciprofloxacin and enoxacin,” Journal of Inorganic Biochemistry, vol. 99, no. 3, pp. 677–689, 2005. View at Publisher · View at Google Scholar
  16. A. W. Bauer, W. M. Kirby, J. C. Sherris, and M. Turck, “Antibiotic susceptibility testing by a standardized single disk method,” American Journal of Clinical Pathology, vol. 45, no. 4, pp. 493–496, 1966. View at Google Scholar
  17. S. L. Helfand, J. Werkmeister, and J. C. Roder, “Chemiluminescence response of human natural killer cells—I: the relationship between target cell binding, chemiluminescence, and cytolysis,” Journal of Experimental Medicine, vol. 156, no. 2, pp. 492–505, 1982. View at Google Scholar
  18. M. E. El-Kommos, G. A. Saleh, S. M. El-Gizawi, and M. A. Abou-Elwafa, “Spectrofluorometric determination of certain quinolone antibacterials using metal chelation,” Talanta, vol. 60, no. 5, pp. 1033–1050, 2003. View at Publisher · View at Google Scholar
  19. W. Guangguo, W. Guoping, F. Xuchun, and Z. Longguan, “Synthesis, crystal structure, stacking effect and antibacterial, studies of a novel quaternary copper (II) complex with quinolone,” Molecules, vol. 8, pp. 287–296, 2003. View at Google Scholar
  20. S. Lecomte, M. H. Baron, M. T. Chenon, C. Coupry, and N. J. Moreau, “Effect of magnesium complexation by fluoroquinolones on their antibacterial properties,” Antimicrobial Agents and Chemotherapy, vol. 38, no. 12, pp. 2810–2816, 1994. View at Google Scholar
  21. J. R. Anacona and C. Toledo, “Synthesis and antibacterial activity of metal complexes of ciprofloxacin,” Transition Metal Chemistry, vol. 26, no. 1-2, pp. 228–231, 2001. View at Publisher · View at Google Scholar
  22. E. K. Efthimiadou, Y. Sanakis, N. Katsaros, A. Karaliota, and G. Psomas, “Transition metal complexes with the quinolone antibacterial agent pipemidic acid: synthesis, characterization and biological activity,” Polyhedron, vol. 26, no. 5, pp. 1148–1158, 2007. View at Publisher · View at Google Scholar
  23. T. Skauge, I. Turel, and E. Sletten, “Interaction between ciprofloxacin and DNA mediated by Mg2+-ions,” Inorganica Chimica Acta, vol. 339, pp. 239–247, 2002. View at Publisher · View at Google Scholar
  24. M. Imran, J. Iqbal, S. Iqbal, and N. Ijaz, “In vitro antibacterial studies of ciprofloxacin-imines and their complexes with Cu(II),Ni(II),Co(II), and Zn(II),” Turkish Journal of Biology, vol. 31, no. 2, pp. 67–72, 2007. View at Google Scholar
  25. P. Drevenšek, J. Košmrlj, G. Giester et al., “X-Ray crystallographic, NMR and antimicrobial activity studies of magnesium complexes of fluoroquinolones—racemic ofloxacin and its S-form, levofloxacin,” Journal of Inorganic Biochemistry, vol. 100, no. 11, pp. 1755–1763, 2006. View at Publisher · View at Google Scholar
  26. M. Tumer, H. Koksal, M. K. Sener, and S. Serin, “Antimicrobial activity studies of the binuclear metal complexes derived from tridentate Schiff base ligands,” Transition Metal Chemistry, vol. 24, no. 4, pp. 414–420, 1999. View at Google Scholar
  27. D. Petra, Z. Tatjana, P. Boris et al., “Mixed-valence Cu(II)/Cu(I) complex of quinolone ciprofloxacin isolated by a hydrothermal reaction in the presence of l-histidine: comparison of biological activities of various copper-ciprofloxacin compounds,” Journal of Inorganic Biochemistry, vol. 99, no. 2, pp. 432–442, 2005. View at Publisher · View at Google Scholar
  28. S. C. Tauber and R. Nau, “Immunomodulatory properties of antibiotics,” Current Molecular Pharmacology, vol. 1, pp. 68–79, 2008. View at Google Scholar
  29. N. Sultana and M. S. Arayne, “In vitro activity of cefadroxil, cephalexin, cefatrizine and cefpirome in presence of essential and trace elements,” Pakistan Journal of Pharmaceutical Sciences, vol. 20, no. 4, pp. 305–310, 2007. View at Google Scholar